FDA extends Class I UDI submission deadline, exempts consumer health devices from requirements

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 02, 2022 at 11:12: AM
via The Food and Drug Administration has given manufacturers of certain Class I and unclassified devices another 75 calendar days to comply with Global Unique Device Identification Database (GUDID) submission requirements.

article source
 

<



Similar threads

cafead
ESMO: AstraZeneca&#039;s Imfinzi extends life in bladder cancer type. Will FDA push back on its perioperative trial design?
Replies
0
Views
23
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Another delay for Ascendis&#039; hormone therapy as FDA extends review by 3 months
Replies
1
Views
208
Pharma/Biotech Companies - In the News
anonymous
cafead
CEL-SCI&#039;s multi-decade Multikine journey extends with FDA request for new trial
Replies
0
Views
112
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA extends deadline to decide on Gamida Cell&#039;s stem cell transplant therapy by three...
Replies
0
Views
151
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Regeneron&#039;s bid for COVID-19 drug&#039;s full approval hits snag as FDA extends review
Replies
0
Views
338
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote